Though vasculitic diseases have been claimed to be associated with anti-endothelial cells antibodies (AECA), there is a widespread awareness of the limitations of the tests currently in use. Our objective was therefore to establish clones, in the hope that some of them would express disease-specific membrane autoantigens. Two EC lines and 7 clones were estab lished by fusing human umbilical vein EC with epithelial A549/8 cells, and cloning by limit ing dilution. An additional clone was derived from the EA.hy 926 cell line. All clones carried EC markers, such as thrombomoduline (TM) and platelet-EC adhesion molecule 1 but differed from each other, depending on whether they expressed HLA class II antigen, LFA-1, thrombospondin receptor or von Willebrand factor (vWf) antigen. Clones were also characterized by their ability to release tissue plasminogen activator, interleukin 6, TM and vWf. This panel is meant to distinguish reactivities of AECA.
Tan EM, Pearson CMRheumatic disease sera reactive with capillaries in the mouse kidney . Arthritis Rheum1972; 15: 23-8.
3.
Cines DB, Lyss AP, Reeber M., Bina M., DeHoratius RJPresence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest1984; 73: 611-25.
4.
Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MHAnti-endothelial antibodies and coronary artery disease after cardiac transplantation . Lancet1992; 339: 1566-70.
5.
van der Zee JM, Heurkens Ahm, van der Woort Eam, Daha MR, Breedveld FCCharacterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Rheumatol1991; 9: 589-95.
6.
Rosenbaum J. , Pottinger BE, Woo P., Black CM, Loizou S., Byron MA, Pearson JDCharacterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol1988; 72: 450-6.
7.
Del Papa N., Conforti G., Gambini D., La Rosa L., Tincani A., D'Cruz D., Khamashta M., Hughes Grv, Balestrieri G., Meroni PLCharacterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis . Clin Immunol Immunopathol1994; 70: 211-6.
8.
Adler Y., Salozhin K., Le Tonquèze M., Shoenfeld Y., Youinou P.Anti-endothelial cell antibodies: a need for standardization. Lupus1994; 3: 77-84.
9.
Meroni PL, Khamashta MA, Youinou P., Shoenfeld Y.Mosaic of anti-endothelial antibodies. Review of the first international workshop on anti-endothelial antibodies. Clinical and pathological significance . Lupus1995; 4: 95-9.
10.
Youinou P., Meroni PL, Khamashta MA, Shoenfeld Y.A need for standardization of the anti-endothelial cell antibody test . Immunol Today1995; 16: 363-4.
11.
Jaffe EA, Hoyer LW, Nachman RLSynthesis of von Willebrand factor by cultured endothelial cells. Proc Natl Acad Sci USA1974; 71: 1906-9.
12.
Esmon CT, Owen WGIdentification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA1981; 78: 2249-52.
13.
Levin EG, Marzec U., Anderson J., Harker LAThrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest1984 ; 74: 1988-95.
14.
van Mowrik JA, Lawrence DA, Loskutoff DJPurification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells . J Biol Chem1984; 10: 14914-21.
15.
Woolf AD, Wakerley G., Wallington TB, Scott Dgi, Dieppe PAFactor VIII-related antigen in the assessment of vasculitis. Ann Rheum Dis1987; 46: 441-7.
16.
Böhme MW, Nawroth PP, Kling E., Lin L., Amiral J., Riedesel J., Raeth U., Scherbaum WASerum thrombomodulin, a novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum1994; 37: 572-7.
17.
Carlos TM, Harlan JMLeucocyte-endothelial adhesion molecules. Blood1994; 84: 2068-101.
18.
Pober JS, Gimbrone MA, Cotran RS, Reiss CS, Burakoff SJ, Fiers W., Ault KAIa expression by vascular endothelium is inducible by activated T cells and by human γ interferon. J Exp Med1983; 157: 1339-53.
19.
Hirschberg H., Bergh OJ, Thorsby E.Antigen-presenting properties of human vascular endothelial cells. J Exp Med1980; 152: 249-55.
20.
Mantovani A. , Dejana E.Cytokines as communication signals between leucocytes and endothelial cells. Immunol Today1989; 10: 370-5.
21.
Edgell Cjs, McDonald CC, Graham JBPermanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA1983 ; 80: 3734-37.
22.
Edgell Cjs, Reisner HM, Graham JBEndothelial cell hybrids and the suspension of factor VIII related antigen expression. Br J Haematol1980; 46: 613-20.
23.
Edgell CJ, Gazdaz AF, Minna JDExpression of feline xenotropic RNA tumor virus in hybrids between permissive human cells and non-permissive mouse cells. Int J Cancer1979; 24: 826-34.
24.
Jaffe EA, Nachman RI, Becker CG, Minick CRCulture of human endothelial cells derived from umbilical veins. J Clin Invest1973; 52: 2745-56.
25.
Leiber M., Smith B., Szakal A., Raes NW, Todaro GJA continuous tumor cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer1976; 17: 62-70.
26.
Ziegler ML, Davidson RLElimination of mitochondrial elements and improved viability in hybrid cells . Somatic Cell Genetics1981; 7: 73-88.
Gelehrter TO , Sznycer Laszuk R.Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells. J Clin Invest1986; 77: 165-9.
29.
Srinivas U. , Larson M., Lundblad A., Forsum U.E selectin involvement in in vitro adhesion of blood dendritic cells to human umbilical cord endothelial cells. Scand J Immunol1993; 38: 273-8.
30.
Mueller SN, Rosen EM, Levine EMCellular senescence in a cloned strain of bovine fetal aortic endothelial cells. Science1984; 207:889-91.
31.
Ringertz NR, Savage REPhenotypic expression in hybrid cell. In: Cell Hybrids . Academic Press: New York, 1976, 180-212.
32.
Pober JS, Cotran RSImmunologic interactions of T lymphocytes with vascular endothelium . Adv Immunol1991; 50: 261-302.
33.
Brisson C., Archipoff G., Hartmann ML, Hanau D., Beretz A., Freyssinet SM, Cazenave JPAntibodies to thrombomodulin in human saphenous vein endothelial cells . Thromb Haemost1992; 68: 737-43.
34.
Kurokawa T. , Toyoda Y., Iwasa S.Characterization of monoclonal antibodies against human tissue plasminogen activator (tPA): Quantitation of free tPA in human cell cultures by an ELISA. J Biochem1991; 109: 217-22.
